TCR2 THERAPEUTICS INC. Quarterly Return On Assets in % from Q3 2019 to Q1 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Tcr2 Therapeutics Inc. quarterly/annual Return On Assets history and growth rate from Q3 2019 to Q1 2023.
  • Tcr2 Therapeutics Inc. Return On Assets for the quarter ending March 31, 2023 was -69.4 %, a 120% decline year-over-year.
  • Tcr2 Therapeutics Inc. annual Return On Assets for 2022 was -54.6 %, a 96.1% decline from 2021.
  • Tcr2 Therapeutics Inc. annual Return On Assets for 2021 was -27.8 %, a 17% increase from 2020.
  • Tcr2 Therapeutics Inc. annual Return On Assets for 2020 was -33.5 %, a 29.7% decline from 2019.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q1 2023 -69.4 -37.8 -120% Jan 1, 2023 Mar 31, 2023
Q4 2022 -54.6 -26.8 -96.1% Oct 1, 2022 Dec 31, 2022
Q3 2022 -38.8 -12.1 -45.4% Jul 1, 2022 Sep 30, 2022
Q2 2022 -35.3 -9.71 -38% Apr 1, 2022 Jun 30, 2022
Q1 2022 -31.6 -3.53 -12.6% Jan 1, 2022 Mar 31, 2022
Q4 2021 -27.8 +5.7 +17% Oct 1, 2021 Dec 31, 2021
Q3 2021 -26.7 +7.34 +21.6% Jul 1, 2021 Sep 30, 2021
Q2 2021 -25.6 +10.9 +29.8% Apr 1, 2021 Jun 30, 2021
Q1 2021 -28 +2.74 +8.91% Jan 1, 2021 Mar 31, 2021
Q4 2020 -33.5 -7.67 -29.7% Oct 1, 2020 Dec 31, 2020
Q3 2020 -34 -9.66 -39.6% Jul 1, 2020 Sep 30, 2020
Q2 2020 -36.4 Apr 1, 2020 Jun 30, 2020
Q1 2020 -30.8 Jan 1, 2020 Mar 31, 2020
Q4 2019 -25.9 Oct 1, 2019 Dec 31, 2019
Q3 2019 -24.4 Jul 1, 2019 Sep 30, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.